{"id":"W3202877676","doi":"10.1016/j.annonc.2021.08.1134","title":"621P Efficacy and safety of relugolix vs leuprolide (LEU) in men with advanced prostate cancer (APC): Clinical subgroup analysis from the phase III HERO study","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital Saint-Luc","funders":"Plexxikon; Ipsen; Astellas Pharma; Upsher-Smith; Prothena; Flatiron Health; Sunesis; Sanofi; Exelixis; Genomic Health; Medpace; AstraZeneca; Pfizer; Amgen","keywords":"Medicine; Prostate cancer; Subgroup analysis; Oncology; Internal medicine; HERO; Gynecology; Cancer; Phases of clinical research; Clinical trial; Meta-analysis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002393681,0.001179452,0.00303595,0.0004311448,0.0002518393,0.001082792,0.0005164027,0.0006871992,0.002251093],"category_scores_gemma":[0.001915137,0.0003467855,0.005074066,0.0005720485,0.0004594101,0.0006474131,0.0004600521,0.001632469,0.0002728111],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005730882,"about_ca_system_score_gemma":0.0005963802,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007569849,"about_ca_topic_score_gemma":0.002383634,"domain_scores_codex":[0.9990413,0.0005242215,0.00007408464,0.0001523087,0.00009432346,0.0001137394],"domain_scores_gemma":[0.9991449,0.0003534046,0.0002181041,0.0001133396,0.00003627072,0.0001339456],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8928097,0.001092058,0.02419849,0.001212996,0.02556274,0.000131512,0.00009371808,0.002083084,0.00589879,0.0001933081,0.001704231,0.04501923],"study_design_scores_gemma":[0.5600836,0.1369352,0.2083172,0.0003846691,0.07498447,0.0006495338,0.0004007669,0.005513274,0.003686349,0.002576589,0.006230855,0.000237505],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9855331,0.01110331,0.0003372639,0.0003497867,0.0001254717,0.0002231174,0.001323519,0.00004031914,0.0009642472],"genre_scores_gemma":[0.9948389,0.002065135,0.0002809393,0.0003151218,0.0001407278,0.0001735289,0.001536447,0.0000205369,0.0006287103],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00303595,"threshold_uncertainty_score":0.01265913,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0915332718256188,"score_gpt":0.4870020442695029,"score_spread":0.3954687724438841,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}